GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxil Bio Ltd (TSXV:VXL) » Definitions » YoY EPS Growth

Vaxil Bio (TSXV:VXL) YoY EPS Growth : -14.29% (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Vaxil Bio YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Vaxil Bio's YoY EPS Growth for the quarter that ended in Dec. 2023 was -14.29%.

Vaxil Bio's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was C$-0.01.

Vaxil Bio YoY EPS Growth Historical Data

The historical data trend for Vaxil Bio's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxil Bio YoY EPS Growth Chart

Vaxil Bio Annual Data
Trend May14 May15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vaxil Bio Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -40.00 - - 100.00 -14.29

Vaxil Bio YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Vaxil Bio's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(-0.01--0.01)/ | -0.01 |
=0.00 %

Vaxil Bio's YoY EPS Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EPS Growth (Q: Dec. 2023 )
=(Earnings per Share (Diluted) (Q: Dec. 2023 )-Earnings per Share (Diluted) (Q: Dec. 2022 )) / | Earnings per Share (Diluted) (Q: Dec. 2022 )) |
=(-0.008--0.007)/ | -0.007 |
=-14.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxil Bio YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Vaxil Bio's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaxil Bio (TSXV:VXL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxil Bio Ltd (TSXV:VXL) » Definitions » YoY EPS Growth
Comparable Companies
XCNQ:NIRV TSXV:WAVE TSXV:SVS XCNQ:CMND TSX:IPCI TSXV:MRVL TSXV:PSYB XCNQ:CURE XCNQ:AGN XCNQ:MOOD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
VXLLF:USA
Address
C/O Kira Lynn, Bennet Jones LLP, 3400 One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Website
https://www.vaxil-bio.com
Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on a novel drug discovery and development platform based on Signal Peptides which the company deploys to fight infectious diseases and cancer.

Vaxil Bio (TSXV:VXL) Headlines

No Headlines